140 related articles for article (PubMed ID: 38241616)
21. Discontinuation of anti-PD-1 monotherapy in advanced melanoma-Outcomes of daily clinical practice.
van Zeijl MCT; van den Eertwegh AJM; Wouters MWJM; de Wreede LC; Aarts MJB; van den Berkmortel FWPJ; de Groot JB; Hospers GAP; Kapiteijn E; Piersma D; van Rijn RS; Suijkerbuijk KPM; Ten Tije AJ; van der Veldt AAM; Vreugdenhil G; van der Hoeven JJM; Haanen JBAG
Int J Cancer; 2022 Jan; 150(2):317-326. PubMed ID: 34520567
[TBL] [Abstract][Full Text] [Related]
22. [Incidence of benign and malignant lesions of eyelid and conjunctival tumors].
Obata H; Aoki Y; Kubota S; Kanai N; Tsuru T
Nippon Ganka Gakkai Zasshi; 2005 Sep; 109(9):573-9. PubMed ID: 16218435
[TBL] [Abstract][Full Text] [Related]
23. Sentinel lymph node biopsy for eyelid and conjunctival tumors: what have we learned in the past decade?
Pfeiffer ML; Savar A; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2013; 29(1):57-62. PubMed ID: 23299810
[TBL] [Abstract][Full Text] [Related]
24. Handheld In Vivo Reflectance Confocal Microscopy for the Diagnosis of Eyelid Margin and Conjunctival Tumors.
Cinotti E; Singer A; Labeille B; Grivet D; Rubegni P; Douchet C; Cambazard F; Thuret G; Gain P; Perrot JL
JAMA Ophthalmol; 2017 Aug; 135(8):845-851. PubMed ID: 28654937
[TBL] [Abstract][Full Text] [Related]
25. New Therapeutic Approaches for Conjunctival Melanoma-What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells.
Peil J; Bock F; Kiefer F; Schmidt R; Heindl LM; Cursiefen C; Schlereth SL
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163401
[TBL] [Abstract][Full Text] [Related]
26. Conjunctival lymphoid tumors: clinical analysis of 117 cases and relationship to systemic lymphoma.
Shields CL; Shields JA; Carvalho C; Rundle P; Smith AF
Ophthalmology; 2001 May; 108(5):979-84. PubMed ID: 11320031
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of Rituximab in CANOMAD: A Systematic Review.
Aguirre AS; Vivanco RA; Ortiz JF; Rozen V; InsuastI WE; Fiallos J; Gallegos C; Villavicencio A; Salazar K; Duenas F; Singla R
Cureus; 2023 May; 15(5):e39237. PubMed ID: 37337500
[TBL] [Abstract][Full Text] [Related]
28. [Current Therapies in Superficial Malignant Tumors].
Scholz SL; Eckstein A; Dekowski D; Esser J; Westekemper H; Steuhl KP
Laryngorhinootologie; 2019 Oct; 98(10):685-694. PubMed ID: 31610596
[TBL] [Abstract][Full Text] [Related]
29. Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma.
Alva A; Daniels GA; Wong MK; Kaufman HL; Morse MA; McDermott DF; Clark JI; Agarwala SS; Miletello G; Logan TF; Hauke RJ; Curti B; Kirkwood JM; Gonzalez R; Amin A; Fishman M; Agarwal N; Lowder JN; Hua H; Aung S; Dutcher JP
Cancer Immunol Immunother; 2016 Dec; 65(12):1533-1544. PubMed ID: 27714434
[TBL] [Abstract][Full Text] [Related]
30. [Conjunctival squamous cell carcinoma. Four cases reported in the French West Indies].
Acis D; Donnio A; Ayéboua L; Richer R; Guyomarch J; Warter A; Merle H
J Fr Ophtalmol; 2008 May; 31(5):533.e1-5. PubMed ID: 18641577
[TBL] [Abstract][Full Text] [Related]
31. [The clinical and histopathological analysis of 2 053 cases of conjunctival neoplasms].
Huang JJ; Li B; Liang QF; Xu XL; Gao F; Zhang ZB
Zhonghua Yan Ke Za Zhi; 2016 Oct; 52(10):738-744. PubMed ID: 27760645
[No Abstract] [Full Text] [Related]
32. Topical mitomycin C and radiation induce conjunctival DNA-polyploidy.
Cartsburg O; Kallen C; Hillenkamp J; Sundmacher R; Pomjanski N; Böcking A
Anal Cell Pathol; 2001; 23(2):65-74. PubMed ID: 11904462
[TBL] [Abstract][Full Text] [Related]
33. Intralesional interferon-α for conjunctival mucosa-associated lymphoid tissue lymphoma: long-term results.
Blasi MA; Tiberti AC; Valente P; Laguardia M; Sammarco MG; Balestrazzi A; Larocca LM; Balestrazzi E
Ophthalmology; 2012 Mar; 119(3):494-500. PubMed ID: 22226154
[TBL] [Abstract][Full Text] [Related]
34. Rituximab immunotherapy for ocular adnexal lymphoma: clinicopathologic correlation with 5-year follow-up.
Sokol JA; Landau L; Lauer SA
Ophthalmic Plast Reconstr Surg; 2009; 25(4):322-4. PubMed ID: 19617799
[TBL] [Abstract][Full Text] [Related]
35. Factors affecting recurrence and metastasis in conjunctival melanoma.
Çalış Karanfil F; Gündüz AK; Gündüz ÖÖ; Özalp Ateş FS
Int Ophthalmol; 2023 Nov; 43(11):4203-4215. PubMed ID: 37639080
[TBL] [Abstract][Full Text] [Related]
36. Pigmented conjunctival squamous cell carcinoma simulating a conjunctival melanoma.
Shields JA; Shields CL; Eagle RC; Singh AD; Demirci H; Wolf MA
Am J Ophthalmol; 2001 Jul; 132(1):104-6. PubMed ID: 11438062
[TBL] [Abstract][Full Text] [Related]
37. Treatment response and recurrence of conjunctival melanoma with orbital invasion treated with immune checkpoint inhibitors: case report and literature review.
Alhammad FA; Alburayk KB; Albadri KS; Butt SA; Azam F
Orbit; 2024 Feb; 43(1):49-57. PubMed ID: 37052129
[TBL] [Abstract][Full Text] [Related]
38. [777 cases of the primary conjunctival neoplasms].
Feng G; Yi Y; Li Y
Yan Ke Xue Bao; 1995 Dec; 11(4):211-5. PubMed ID: 9275748
[TBL] [Abstract][Full Text] [Related]
39. [A retrospective analysis of 147 cases of orbital exenteration].
Zhao HS; Wei WB; Shi JT
Zhonghua Yan Ke Za Zhi; 2023 May; 59(5):388-397. PubMed ID: 37151008
[No Abstract] [Full Text] [Related]
40. First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.
Walewski J; Paszkiewicz-Kozik E; Michalski W; Rymkiewicz G; Szpila T; Butrym A; Giza A; Zaucha JM; Kalinka-Warzocha E; Wieczorkiewicz A; Zimowska-Curyło D; Knopińska-Posłuszny W; Tyczyńska A; Romejko-Jarosińska J; Dąbrowska-Iwanicka A; Gruszecka B; Jamrozek-Jedlińska M; Borawska A; Hołda W; Porowska A; Romanowicz A; Hellmann A; Stella-Hołowiecka B; Deptała A; Jurczak W
Br J Haematol; 2020 Mar; 188(6):898-906. PubMed ID: 31792945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
